Article
mRNA m5C Alteration in Azacitidine Demethylation Treatment of Acute Myeloid Leukemia
17 Dec 2024
Abstract excerpt
The DNA demethylating therapy with azacitidine (AZA) is a promising therapeutic strategy for elderly patients with acute myeloid leukemia (AML). AZA primarily inhibits DNA methylation, promotes cell differentiation and apoptosis in AML. However, as a cytosine nucleoside analog, AZA also has the potential to be incorporated into RNA molecules. To assess the impact of AZA on RNA m5C methylation during demethylating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
